Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Helius Medical Technologies Inc (HSDT)

Helius Medical Technologies Inc (HSDT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 42,224
  • Shares Outstanding, K 25,904
  • Annual Sales, $ 480 K
  • Annual Income, $ -28,620 K
  • 60-Month Beta -0.17
  • Price/Sales 87.25
  • Price/Cash Flow N/A
  • Price/Book 2.95

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -0.22
  • Number of Estimates 1
  • High Estimate -0.22
  • Low Estimate -0.22
  • Prior Year -0.19
  • Growth Rate Est. (year over year) -15.79%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.44 +13.19%
on 10/15/19
1.86 -12.37%
on 09/19/19
-0.12 (-6.86%)
since 09/18/19
3-Month
1.44 +13.19%
on 10/15/19
2.42 -32.64%
on 07/22/19
-0.66 (-28.82%)
since 07/18/19
52-Week
1.44 +13.19%
on 10/15/19
10.76 -84.85%
on 11/09/18
-7.20 (-81.54%)
since 10/18/18

Most Recent Stories

More News
Helius Medical Technologies to Release Third Quarter of Fiscal Year 2019 Financial Results on November 12, 2019

Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that third quarter of fiscal year 2019 financial...

HSDT : 1.63 (+1.24%)
HSM.TO : 2.14 (-2.73%)
Helius Medical Technologies, Inc. and HealthTech Connex Announce Grand Opening of Canada's Fifth PoNS Treatment(TM) Clinic

Helius Medical Technologies, Inc. and HealthTech Connex, leading providers of innovative neurological health solutions, announce the grand opening of Apollo Physical Therapy Centre ("Apollo"), Canada's...

HSDT : 1.63 (+1.24%)
Helius Medical Technologies, Inc. and HealthTech Connex Announce the Grand Opening of Alberta's First Authorized PoNS Treatment(TM) Clinic at Synaptic Spinal Cord Injury and Neuro Rehabilitation Centre

The Calgary based clinic offers revolutionary neurological health technologies for traumatic brain injury management

HSDT : 1.63 (+1.24%)
Helius Medical Technologies, Inc. Announces Addition of a New PoNS(TM) Clinic in Quebec City, Canada

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today reported that Clinique Cortex has been authorized to provide...

HSDT : 1.63 (+1.24%)
HSM.TO : 2.14 (-2.73%)
MONDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Helius Medical Technologies, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Helius Medical Technologies, Inc. ("Helius" or "the Company") (NASDAQ: HSDT) for...

HSDT : 1.63 (+1.24%)
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Helius Medical Technologies (NASDAQ: HSDT) and Encourages Helius Investors to Contact the Firm

Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all investors that purchased Helius...

HSDT : 1.63 (+1.24%)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Helius Medical Technologies, Inc. of Class Action Lawsuit and Upcoming Deadline - HSDT

Pomerantz LLP announces that a class action lawsuit has been filed against Helius Medical Technologies, Inc. ("Helius" or the "Company") (NASDAQ: HSDT) and certain of its officers. The class action,...

HSDT : 1.63 (+1.24%)
DEADLINE ALERT - Helius Medical Technologies, Inc. (HSDT) - Bronstein, Gewirtz & Grossman, LLC Announces Class Action and Lead Deadline: September 9, 2019

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Helius Medical Technologies, Inc. ("Helius" or the "Company") (NASDAQ: HSDT)...

HSDT : 1.63 (+1.24%)
ROSEN, A TOP RANKED LAW FIRM, Reminds Helius Medical Technologies, Inc. Investors of Important Monday Deadline in Securities Class Action - HSDT

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Helius Medical Technologies, Inc. (NASDAQ: HSDT) from November 9, 2017 through April 10, 2019, inclusive (the...

HSDT : 1.63 (+1.24%)
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Helius Medical Technologies (NASDAQ: HSDT) and Encourages Helius Investors to Contact the Firm

Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all investors that purchased Helius...

HSDT : 1.63 (+1.24%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade HSDT with:

Business Summary

Helius Medical Technologies Inc. is a specialty medical device company. It is focused on the development and regulatory approval of its non-invasive neurostimulation device called PoNS. The Company is nearing clinical trials for balance disorders in TBI patients and for the treatment of MS. Helius Medical...

See More

Key Turning Points

2nd Resistance Point 1.74
1st Resistance Point 1.69
Last Price 1.63
1st Support Level 1.60
2nd Support Level 1.56

See More

52-Week High 10.76
Fibonacci 61.8% 7.20
Fibonacci 50% 6.10
Fibonacci 38.2% 5.00
Last Price 1.63
52-Week Low 1.44

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar